Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Nymox Pharmaceutical Corp

Nymox Pharmaceutical Corp (NYMX)

Market is closed
News
  • Displaying 10
Hedge Fund and Insider Trading News: Leon Cooperman, Ken Griffin, Cathie Wood, Precipio Capital, Align Technology, Inc. (ALGN), and More

Hedge Fund and Insider Trading News: Leon Cooperman, Ken Griffin, Cathie Wood, Precipio Capital, Align Technology, Inc. (ALGN), and More

Jeffrey Ryan, one of the founding employees of Citadel's quantitative finance team, is making a comeback. In crypto.

Keep Reading →

May 6th, 2022 - Hedge Funds Insider Trading

Hedge Funds Cautiously Watching Pharmaceutical Corporation (NYMX)

Hedge Funds Cautiously Watching Pharmaceutical Corporation (NYMX)

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...

Keep Reading →

June 5th, 2020 - Hedge Funds News

Hedge Funds Have Never Been More Bullish On Nymox Pharmaceutical Corporation (NYMX)

Hedge Funds Have Never Been More Bullish On Nymox Pharmaceutical Corporation (NYMX)

We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.

Keep Reading →

December 23rd, 2019 - Hedge Funds News

Hedge Fund and Insider Trading News: David Einhorn, Alan Howard, Philippe Laffont, Nymox Pharmaceutical Co. (NYMX), ALJ Regional Holdings, Inc. (ALJJ), and More

Hedge Fund and Insider Trading News: David Einhorn, Alan Howard, Philippe Laffont, Nymox Pharmaceutical Co. (NYMX), ALJ Regional Holdings, Inc. (ALJJ), and More

Hedge fund manager David Einhorn said a shift in favor of value stocks may soon be coming even after his firm posted its worst underperformance in almost two decades.

Keep Reading →

February 21st, 2018 - Hedge Funds Insider Trading

Nymox Pharmaceutical Corporation (NYMX) Has More Upside Potential, Even After Gains

Nymox Pharmaceutical Corporation (NYMX) Has More Upside Potential, Even After Gains

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) just put out data from its long term investigation into the safety and efficacy of its lead prostate candidate, and the company is up nearly 83% on the news...

Keep Reading →

August 25th, 2016 - News Stock Analysis

Here's Why These Five Stocks Are on the Move Today

Here's Why These Five Stocks Are on the Move Today

Among the stocks showing more volatility than the indexes are MBIA Inc.

Keep Reading →

June 22nd, 2016 - Market Movers News

Nymox Pharmaceutical Corporation (NYMX) and 2 Banks Witness Notable Insider Buying

Nymox Pharmaceutical Corporation (NYMX) and 2 Banks Witness Notable Insider Buying

The Dow Jones Industrial Average is on track to reach a new all-time high after registering the worst five-day start to a year in its history.

Keep Reading →

April 18th, 2016 - Dividend Stocks Insider Trading News

Nymox Pharmaceutical Corporation (NYMX) Jumps On News Of Study Results

Nymox Pharmaceutical Corporation (NYMX) Jumps On News Of Study Results

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced on Monday that its phase 3 studies of fexapotide triflutate for BPH, NX02-0017, and NX02-0018, have successfully attained the targeted primary...

Keep Reading →

July 28th, 2015 - Hedge Funds Market Movers News

This Metric Says You Are Smart to Buy Trinity Biotech plc (ADR) (TRIB)

If you'd ask most market participants, hedge funds are seen as slow, outdated investment vehicles of years past.

Keep Reading →

June 19th, 2013 - News

Hedge Funds Are Dumping Trinity Biotech plc (ADR) (TRIB)

In the financial world, there are tons of indicators market participants can use to watch Mr. Market. Some of the most underrated are hedge fund and insider trading sentiment.

Keep Reading →

April 18th, 2013 - News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)